Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.40
+0.44 (4.91%)
Mar 9, 2026, 2:18 PM EDT - Market open
Kura Oncology Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Kura Oncology stock have an average target of 26.63, with a low estimate of 11 and a high estimate of 40. The average target predicts an increase of 183.30% from the current stock price of 9.40.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Kura Oncology stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 2 | 2 | 2 | 2 | 2 |
| Buy | 6 | 7 | 7 | 7 | 7 | 7 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 11 | 11 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $38 → $36 | Buy | Maintains | $38 → $36 | +282.98% | Mar 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +325.53% | Jan 13, 2026 |
| Barclays | Barclays | Buy Maintains $11 → $28 | Buy | Maintains | $11 → $28 | +197.87% | Nov 24, 2025 |
| UBS | UBS | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +70.21% | Nov 14, 2025 |
| Wedbush | Wedbush | Buy Maintains $36 → $38 | Buy | Maintains | $36 → $38 | +304.26% | Nov 14, 2025 |
Financial Forecast
Revenue This Year
151.18M
from 67.48M
Increased by 124.03%
Revenue Next Year
194.47M
from 151.18M
Increased by 28.63%
EPS This Year
-3.22
from -3.18
EPS Next Year
-2.68
from -3.22
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 337.8M | 551.3M | |||
| Avg | 151.2M | 194.5M | |||
| Low | 60.5M | 52.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 400.6% | 264.6% | |||
| Avg | 124.0% | 28.6% | |||
| Low | -10.4% | -65.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.60 | -1.67 | |||
| Avg | -3.22 | -2.68 | |||
| Low | -3.77 | -3.20 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.